Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 6, 2025 • 12:00 PM ET

Date/Time Source News Release
03/24/2025 09:00 AM EDT GlobeNewswire Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol
03/20/2025 09:45 AM EDT GlobeNewswire Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market
03/19/2025 09:00 AM EDT GlobeNewswire Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
03/18/2025 08:30 AM EDT GlobeNewswire Can-Fite: FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient
03/03/2025 06:00 AM EST GlobeNewswire Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
02/18/2025 07:00 AM EST GlobeNewswire Disappearance of Decompensated Liver Cirrhosis Episodes After Treatment with Can-Fite's Namodenoson
02/10/2025 07:10 AM EST GlobeNewswire Join Can-Fite's Exclusive Live Investor Webinar and Q&A Session on February 25
02/05/2025 07:00 AM EST GlobeNewswire Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
01/27/2025 07:00 AM EST GlobeNewswire US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug
12/30/2024 07:00 AM EST GlobeNewswire Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite's anti-Cancer Drug Namodenoson
Page

Additional News

As of April 6, 2025 • 12:00 PM ET

Date/Time Source News Release
01/27/2025 09:49 AM EST Baystreet Can-Fite Wins Patent, Shares Flat
01/18/2025 11:00 AM EST SeekingAlpha Netflix, Procter & Gamble, Johnson & Johnson Report Results In Holiday-Shortened Week
01/17/2025 03:00 PM EST SeekingAlpha Catalyst Watch: Netflix earnings, Monster Beverage event, drug data, and quantum volatility
01/09/2025 12:00 PM EST Zacks CanFite Biopharma (CANF) Upgraded to Strong Buy: Here's What You Should Know
12/09/2024 09:55 AM EST Zacks Bears are Losing Control Over CanFite Biopharma (CANF), Here's Why It's a 'Buy' Now
10/09/2024 03:22 PM EDT SeekingAlpha Can-Fite stock rallies 17% on FDA orphan drug designation
09/24/2024 07:49 AM EDT SeekingAlpha Can-Fite gains after agreement for animal arthritis drug
08/30/2024 05:12 PM EDT SeekingAlpha Can-Fite BioPharma files to sell 1.77B shares of common stock for holders
08/29/2024 12:37 PM EDT SeekingAlpha Can-Fite Biopharma GAAP EPS of $0.00, revenue of $0.32M
08/25/2024 08:01 AM EDT SeekingAlpha Earnings week ahead: NVIDIA, CrowdStrike, Salesforce, Lululemon and more
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.